Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Evaluation of a Mobile Application to Facilitate the Interpretation of Spirometry by Family Physicians and Residents

8 ottobre 2020 aggiornato da: Louis-Philippe Boulet, Laval University

Evaluation of a Mobile Application to Facilitate the Interpretation of the Spirometry Test by Family Physicians and Family Medicine Residents: Impact on Prescription and Interpretation of This Test

Problematic: Spirometry is used to objectify the obstructive syndrome defining chronic obstructive pulmonary disease (COPD). However, this test remains underused in the primary care. The tools available for its interpretation are little used and the existence of several decision algorithms can create confusion during the diagnosis.

Principal objective: To evaluate the impact of a mobile application (SPIRO©) on medical practice (interpretation and prescription of spirometry) of family physicians and family medicine residents working in family medicine units (FMU) in Quebec affiliated with Laval University.

Secondary objective : To evaluate the usability of SPIRO© among family physicians and residents in family medicine working in FMU in Quebec affiliated with Laval University.

Methods: This is a pre-post clinical trial with control group. Participants (family MD and family medicine residents) will be recruited from the various FMU affiliated with Laval University. Participants working in the FMU in the experimental group will be able to use the SPIRO® mobile application to facilitate interpretation of the spirometry test results while participants in the control group will not have access to it during the study. The basic characteristics of the participants and various behavioral parameters based on the theory of planned behavior concerning the interpretation and prescription of spirometry test will be measured. Data from the control group will be collected before those in the experimental group at the time the application is not yet available, which will minimize contamination between groups. The data will be collected with questionnaires delivered in person to the participants before the intervention (T0 time) and then four months later (T1 time) during their team or research meeting. Participants will be recruited in eight of the 12 Quebec FMU affiliated with Laval University, who will be randomly assigned to two equal groups: control and experimental. The intervention will consist in sending the SPIRO© mobile application to participants in the experimental group who will use it for a period of four months.

Panoramica dello studio

Stato

Completato

Condizioni

Intervento / Trattamento

Descrizione dettagliata

Hypothesis : The investigators hypothesize that the use of the SPIRO© application will increase the skills and confidence of family physicians and family medicine residents in prescribing and interpreting spirometry compared to the control group.

The project will be conducted in the following six major steps: 1) Collection of socio-demographic and behavioral characteristics of participants using sections A, B, C and D of the NAPI questionnaire in the control group; 2) Intervention in the control group (they will continue their daily medical practice without being subject to any intervention by our research team), for a period of 4 months; 3) Measurement of behavioral changes in the control group using Sections B, C, D and E of the NAPI questionnaire 4 months after the start of the study; 4) Collection of socio-demographic and behavioral data from participants in the experimental group using sections A, B, C and D of the NAPI questionnaire; 5) E-mail distribution of the application and use of the application by participants in the experimental group for a period of four months, 6) Measurement of behavioral changes in the experimental group after the use of the application, Using sections B, C, D and E of the NAPI questionnaire as well as a questionnaire on the application SPIRO© (SPIRO questionnaire) which will evaluate the usability of this one.

The study has been approved by the research ethic board of the Health and Social Services Center of the old capital - attached to the Integrated Center for Health and Social Services of the National Capital.

Tipo di studio

Osservativo

Iscrizione (Effettivo)

104

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

  • Canada
    • Quebec
      • Baie-Comeau, Quebec, Canada, G4Z 3B8
        • UMF de Manicouagan
      • Gaspé, Quebec, Canada, G4X 2W2
        • UMF de Gaspé
      • Lac-Etchemin, Quebec, Canada, G0R 1S0
        • UMF des Etchemins
      • Lévis, Quebec, Canada, G6W 0J4
        • UMF de Lévis
      • Quebec City, Quebec, Canada, G1J 2G1
        • Unité de médecine familiale - GMF Maizerets
      • Quebec City, Quebec, Canada, G1L 3L5
        • UMF Saint-François d'Assise
      • Quebec City, Quebec, Canada, G1V 0B7
        • Unité de médecine familiale Laval
      • Trois-Pistoles, Quebec, Canada, G0L 4K0
        • UMF de Trois-Pistoles

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

18 anni e precedenti (Adulto, Adulto più anziano)

Accetta volontari sani

No

Sessi ammissibili allo studio

Tutto

Metodo di campionamento

Campione non probabilistico

Popolazione di studio

Primary care physicians and residents in family medicine of 18 years old or more working in one of the 12 family medicine units in Quebec affiliated with Laval University.

Descrizione

Inclusion Criteria:

  • Participants need to be primary care physicians or residents in family medicine of 18 years old or more working in one of the 12 family medicine units in Quebec affiliated with Laval University.

Exclusion Criteria:

  • Health professionals not practicing family medicine and residents of other specialties will not be eligible. Individuals who participated in the development of the " subjective Norms, Attitudes, Perceived behavioral control, Intentions (NAPI) " questionnaires (apparent validation) will be excluded.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Modelli osservazionali: Coorte
  • Prospettive temporali: Prospettiva

Coorti e interventi

Gruppo / Coorte
Intervento / Trattamento
Control Group
Primary care physicians and residents in family medicine of family medicine units affiliated with Laval University.
Experimental Group
Primary care physicians and residents in family medicine of family medicine units affiliated with Laval University that will use the mobile application SPIRO(c) for a period of four months.
Dispositivo: SPIRO
Participants in the Experimental Group will be asked to use SPIRO mobile application during a period of 4 months.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Beliefs about capabilities - interpretation
Lasso di tempo: six weeks
The beliefs about the capabilities of primary care physicians and residents in family medicine regarding interpretation of spirometry.
six weeks

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Beliefs about consequences - prescription
Lasso di tempo: six weeks
The beliefs about the consequences of primary care physicians and residents in family medicine regarding prescription of spirometry.
six weeks
Beliefs about consequences - interpretation
Lasso di tempo: six weeks
The beliefs about the consequences of primary care physicians and residents in family medicine regarding interpretation of spirometry.
six weeks
Beliefs about consequences - use of a mobile application
Lasso di tempo: six weeks
The beliefs about the consequences of primary care physicians and residents in family medicine regarding the use of a mobile application to interpret spirometry.
six weeks
Moral norms - prescription
Lasso di tempo: six weeks
The beliefs about the moral norms of primary care physicians and residents in family medicine regarding prescription of spirometry.
six weeks
Moral norms - interpretation
Lasso di tempo: six weeks
The beliefs about the moral norms of primary care physicians and residents in family medicine regarding interpretation of spirometry.
six weeks
Moral norms - use of a mobile application
Lasso di tempo: six weeks
The beliefs about the moral norms of primary care physicians and residents in family medicine regarding the use of a mobile application to interpret spirometry.
six weeks
Intentions - prescription
Lasso di tempo: six weeks
The beliefs about the intentions of primary care physicians and residents in family medicine regarding prescription of spirometry.
six weeks
Intentions - interpretation
Lasso di tempo: six weeks
The beliefs about the intentions of primary care physicians and residents in family medicine regarding interpretation of spirometry.
six weeks
Intentions - use of a mobile application
Lasso di tempo: six weeks
The beliefs about the intentions of primary care physicians and residents in family medicine regarding the use of a mobile application to interpret spirometry.
six weeks
Social influence - prescription
Lasso di tempo: six weeks
The beliefs about the social influence of primary care physicians and residents in family medicine regarding prescription of spirometry.
six weeks
Social influence - interpretation
Lasso di tempo: six weeks
The beliefs about the social influence of primary care physicians and residents in family medicine regarding interpretation of spirometry.
six weeks
Social influence - use of a mobile application
Lasso di tempo: six weeks
The beliefs about the social influence of primary care physicians and residents in family medicine regarding the use of a mobile application to interpret spirometry.
six weeks
Belief about capabilities - prescription
Lasso di tempo: six weeks
The beliefs about the belief about capabilities of primary care physicians and residents in family medicine regarding prescription of spirometry.
six weeks
Belief about capabilities - use of a mobile application
Lasso di tempo: six weeks
The beliefs about the belief about capabilities of primary care physicians and residents in family medicine regarding the use of a mobile application to interpret spirometry.
six weeks

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Laval University

Investigatori

  • Investigatore principale: Louis-Philippe Boulet, MD, Heart and Lung Institute

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

1 ottobre 2016

Completamento primario (Effettivo)

7 luglio 2017

Completamento dello studio (Effettivo)

20 dicembre 2017

Date di iscrizione allo studio

Primo inviato

26 giugno 2017

Primo inviato che soddisfa i criteri di controllo qualità

29 giugno 2017

Primo Inserito (Effettivo)

2 luglio 2017

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

12 ottobre 2020

Ultimo aggiornamento inviato che soddisfa i criteri QC

8 ottobre 2020

Ultimo verificato

1 ottobre 2020

Maggiori informazioni

Termini relativi a questo studio

Parole chiave

Altri numeri di identificazione dello studio

  • SPIRO-MD Residents

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

Indeciso

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Prove cliniche su BPCO

Prove cliniche su SPIRO

Cerca prove simili

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

CROs by country

CROs in Tanzania

Condizioni

Malattie rare

Interventi farmacologici

Supplementi dietetici

Sponsor / Collaboratori

Sedi

3
Sottoscrivi